$ANDS ANADYS PHARMACEUTICALS INC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANADYS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANADYS PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ANADYS PHARMACEUTICALS INC for free.
IRS Number: 223193172
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ANDS
Company Address: 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO 92121
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
ANADYS PHARMACEUTICALS INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 24 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.68 | 364,918 | 1,342,898 | 5,152,936 | 5.5 M to 5.2 M (-6.61 %) |
| Oct 24 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.68 | 5,252,700 | 19,329,936 | 5,517,854 | 10.8 M to 5.5 M (-48.77 %) |
| Oct 19 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.68 | 650,100 | 2,392,368 | 10,770,554 | 11.4 M to 10.8 M (-5.69 %) |
| Aug 24 2011 | ANDS | ANADYS PHARMACEUTI ... | Posner Brian S | Director | Option Exercise | A | 0.70 | 25,000 | 17,500 | 25,000 | |
| May 27 2011 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 1.17 | 15,000 | 17,550 | 15,000 | |
| May 27 2011 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 1.17 | 15,000 | 17,550 | 15,000 | |
| May 27 2011 | ANDS | ANADYS PHARMACEUTI ... | Labinger Barry | Director | Option Exercise | A | 1.17 | 3,205 | 3,750 | 3,205 | |
| May 27 2011 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 1.17 | 15,000 | 17,550 | 15,000 | |
| May 27 2011 | ANDS | ANADYS PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 1.17 | 15,000 | 17,550 | 15,000 | |
| Mar 15 2011 | ANDS | ANADYS PHARMACEUTI ... | Labinger Barry | Director | Option Exercise | A | 1.24 | 25,000 | 31,000 | 25,000 | |
| Jan 24 2011 | ANDS | ANADYS PHARMACEUTI ... | Slover Peter T | VP, Finance and Ope ... | Option Exercise | A | 1.29 | 50,000 | 64,500 | 50,000 | |
| Jan 24 2011 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | SVP, Legal Affairs ... | Option Exercise | A | 1.29 | 50,000 | 64,500 | 50,000 | |
| Jan 24 2011 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | SVP, Drug Developme ... | Option Exercise | A | 1.29 | 50,000 | 64,500 | 50,000 | |
| Jan 24 2011 | ANDS | ANADYS PHARMACEUTI ... | Eastwood Kevin L. | SVP, Corporate Deve ... | Option Exercise | A | 1.29 | 25,000 | 32,250 | 25,000 | |
| Jan 24 2011 | ANDS | ANADYS PHARMACEUTI ... | Appleman James R. | SVP, Research & CSO | Option Exercise | A | 1.29 | 50,000 | 64,500 | 50,000 |